[A clofibric acid derivative with hypolipemic and platelet antiaggregant action].
Dănilă
G
G
Nechifor
M
M
Filip
M
M
Păduraru
I
I
Ifrim
C
C
Grădinariu
D
D
Papa
V
V
Manolescu
A
A
Bădescu
A
A
D000818:Animals; D000893:Anti-Inflammatory Agents; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D000960:Hypolipidemic Agents; D007928:Lethal Dose 50; D008055:Lipids / Q000097:blood; D008297:Male; D051379:Mice; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors; D051381:Rats
D000893:Anti-Inflammatory Agents; D000960:Hypolipidemic Agents; D008055:Lipids; D010975:Platelet Aggregation Inhibitors; D002995:Clofibric Acid; C016894:plafibride; D002994:Clofibrate
Derivat al acidului clofibric cu acţiune hipolipemiantă şi antiagregantă plachetară.